I very much appreciate the way that the chairman started the discussion about our bipartisan cooperation in the House Permanent Select Committee on Intelligence, and actually being referred to by Members on both sides of the aisle today. I think that is one of our strong points that we need to work hard at preserving. My colleague from Iowa, my neighbor, said it is important to ask the tough questions in the Permanent Select Committee on Intelligence, and I absolutely agree and I think all of us would. I do not believe we have been timid about doing that, not just recently, but throughout. And I believe that the administration and the intelligence community, regardless of the administration in the office at the moment, is likely to have more confidence that they can speak candidly, forthrightly, that we do not have to pull things out of them begrudgingly if they understand that we use that work well and that we keep the matters that are classified very carefully, close to the chest, and use it well. I would say that I think I would certainly disagree, and I have not heard it here, but I would certainly disagree with any broad-brush, sweeping indictment that there were severe problems with intelligence collection analysis or the way the policy makers used the information.
Doug Bereuter: “I very much appreciate the way that the chairman started the discussion about our bipartisan cooperation in the House…”
Editor's note · Context
Discussing bipartisan cooperation in the House Permanent Select Committee on Intelligence.
Share
More from Doug Bereuter
following the stirring address of the President of Afghanistan this morning, this Member rises to address the urgent need for NATO to augment the International Security Assistance Force, or ISAF. This Member cannot overstate how critical…
Last summer this House overwhelmingly adopted a resolution calling on the citizens of Cyprus to accept a U.N.-sponsored plan designed to end 29 years of separation and to unite the island. During the floor debate, this Member expressed the…
this amendment requires the Agency for Healthcare Research and Quality to spend $12 million for the conduct of research on the comparative effectiveness, cost effectiveness, and safety of drugs, biological products and devices under their…
I would begin by first thanking the distinguished gentleman from New York (Mr. Engel) for his initiative in introducing this legislation in the first place and for working with us to ensure its final action here today. During the past…